Jude Fitzgibbon
Queen Mary University of London
H-index: 56
Europe-United Kingdom
Top articles of Jude Fitzgibbon
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Profiling of copy number alterations using low-coverage whole-genome sequencing informs differential diagnosis and prognosis in primary cutaneous follicle center lymphoma | Modern Pathology | Bence Bátai Laura Kiss Luca Varga Ákos Nagy Jacob Househam | 2024/3/7 |
Targeting lysine demethylase 5 (KDM5) in mantle cell lymphoma | Blood Cancer Journal | Danmei Xu Findlay Bewicke-Copley Karina Close Jessica Okosun Robert Peter Gale | 2024/2/13 |
Defining an Optimized Workflow for Enriching and Analyzing Residual Tumor Populations Using Intracellular Markers | The Journal of Molecular Diagnostics | Eve M Coulter Findlay Bewicke-Copley Maximilian Mossner Trevor A Graham Jude Fitzgibbon | 2024/4/1 |
Large-scale, low-cost, and accurate measurement of cancer evolutionary dynamics from clinical patient samples | Cancer Research | Calum Gabbutt Martí Duran-Ferrer Heather Grant Diego Mallo Ferran Nadeu | 2024/3/22 |
PAIRWISE: Deep learning-powered personalized medicine approach identifies actionable drug combinations in B cell lymphoma | Cancer Research | Chengqi Xu Jake Cohen-Setton Zhouyang Shen Marta Milo Ilkay US | 2024/3/22 |
A Multi-Modal Analysis of Acquired Resistance to Acalabrutinib and Pirtobrutinib Provides Potential Strategies to Augment Treatment Outcome with BTKi Drugs | Blood | Xiaoyun Wu Shariful Islam Derek B Oien Collin Tokheim Alex Beacom | 2023/11/28 |
Integrative phosphoproteomics defines two biologically distinct groups of KMT2A rearranged acute myeloid leukaemia with different drug response phenotypes | Signal Transduction and Targeted Therapy | Pedro Casado Ana Rio-Machin Juho J Miettinen Findlay Bewicke-Copley Kevin Rouault-Pierre | 2023/2/27 |
Evolutionary dynamics of 1,976 lymphoid malignancies predict clinical outcome | medRxiv | Calum Gabbutt Martí Duran-Ferrer Heather Grant Diego Mallo Ferran Nadeu | 2023/11/10 |
Non-coding mutations at enhancer clusters contribute to pancreatic ductal adenocarcinoma | bioRxiv | Minal B Patel Eleni Maniati Santosh S Atanur Debosree Pal Ana Rio-Machin | 2023 |
SCD inhibition preferentially eradicates AML displaying high de novo fatty acid desaturation and synergizes with chemotherapy | bioRxiv | Vilma Dembitz Hannah Lawson Richard Burt Celine Philippe Sophie C James | 2023/8/5 |
Molekulargenetik bei indolenten Lymphomen | Jude Fitzgibbon Oliver Weigert | 2023/12/31 | |
Biallelic TET2 mutations confer sensitivity to 5′-azacitidine in acute myeloid leukemia | JCI insight | Friedrich Stölzel Sarah E Fordham Devi Nandana Wei-Yu Lin Helen Blair | 2023/1/1 |
European standard clinical practice–Key issues for the medical care of individuals with familial leukemia | European Journal of Medical Genetics | Alisa Förster Claudia Davenport Nicolas Duployez Miriam Erlacher Alina Ferster | 2023/4/1 |
The XPO1-FOXC1-HOX Functional Axis Opens New Therapeutic Avenues to Treat DEK-NUP214 AML Patients | Blood | Fadimana Kaya Findlay Bewicke-Copley Pedro Casado Izquierdo Jiexin Zheng Juho Jalmari Miettinen | 2023/11/28 |
Germline predisposition to haematological malignancies: Best practice consensus guidelines from the UK Cancer Genetics Group (UKCGG), CanGene‐CanVar and the NHS England … | British Journal of Haematology | Beverley Speight Helen Hanson Clare Turnbull Steven Hardy James Drummond | 2023/4 |
Allele-Specific Expression of Leukemia Genes Is Associated with Pathogenicity in Poor Risk AML | Blood | Jiexin Zheng Findlay Bewicke-Copley Carlo Vermeulen Pedro Casado Fadimana Kaya | 2023/11/28 |
Longitudinal expression profiling identifies a poor risk subset of patients with ABC-type diffuse large B-cell lymphoma | Blood Advances | Findlay Bewicke-Copley Koorosh Korfi Shamzah Araf Brendan Hodkinson Emil Kumar | 2023/3/14 |
Author Correction: Genome-wide association study identifies susceptibility loci for acute myeloid leukemia | nature communications | Bhuwan Khatri Kandice L Tessneer Astrid Rasmussen Farhang Aghakhanian Tove Ragna Reksten | 2022/10/31 |
CKS1 inhibition depletes leukemic stem cells and protects healthy hematopoietic stem cells in acute myeloid leukemia | Science translational medicine | William Grey Ana Rio-Machin Pedro Casado Eva Grönroos Sara Ali | 2022/6/22 |
Deep Multi-Omics Profiling in Cytogenetically Poor-Risk AML | Blood | Ana Rio-Machin Findlay Bewicke-Copley Jiexin Zheng Pedro Casado Izquierdo Juho J Miettinen | 2022/11/15 |
